News

Deal Announcements

Lux BioSciences Adds $3 Million Venture Capital Debt

Monday, March 21, 2011 5:30:00 AM PDT | VentureDeal Staff
Jersey City, New Jersey  --  Biotechnology company Lux BioSciences has garnered $3 million in a new round of venture capital debt financing, according to an SEC regulatory filing.

Lux is developing medicines to treat the underlying causes of ophthalmic diseases.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1